参 考 文 献

　　1.Davenport A.The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit.Am J Kidney Dis，1997，30（5 Suppl 4）：S20-S27

　　2.Baldwin I.Factors affecting circuit patency and filter‘life’.Contrib Nephrol，2007，156：178-184

　　3.Oudemans-van Straaten HM，Bosman RJ，Koopmans M，et al.Citrate anticoagulation for continuous venovenous hemofiltration.Crit Care Med，2009，37（2）：545-552

　　4.Monchi M，Berghmans D，Ledoux D，et al.Citrate vs.heparin for anticoagulation in continuous venovenous hemofiltration：a prospective randomized study.Intensive Care Med，2004，30（2）：260-265

　　5.Wu MY，Hsu YH，Bai CH，et al.Regional citrate versus heparin anticoagulation for continuous renal replacement therapy：a meta-analysis of randomized controlled trials.Am J Kidney Dis，2012，59（6）：810-818

　　6.Kim IB，Fealy N，Baldwin I，et al.Premature circuit clotting due to likely mechanical failure during continuous renal replacement therapy.Blood Purif，2010，30（2）：79-83

　　7.Boyle M，Baldwin I.Understanding the continuous renal replacement therapy circuit for acute renal failure support：a quality issue in the intensive care unit.AACN Adv Crit Care，2010，21（4）：367-375

　　8.Baldwin I，Bellomo R，Koch B.Blood flow reductions during continuous renal replacement therapy and circuit life.Intensive Care Med，2004，30（11）：2074-2079

　　9.王质刚.血液净化学.第3版.北京：北京科学技术出版社，2010：424-450 连续性肾脏替代治疗